BRCNFOTCDairy ProductsFiscal year ends March 31
Burcon NutraScience Corp
Financials through fiscal 2022, year ended Mar 31, 2022Last filing: 20-F on Aug 1, 2022
$0.92+0.00 (0.00%)
Close on Oct 19, 2026
Margins
Share of revenue, fiscal years 2019 to 2022
Operating margin
-4314.2%
Growth rates
Compound annual growth to fiscal 2022
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -33.7% | – | – | – |
Returns and balance sheet
4 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2019 | FY2019 | FY2022 | Trend |
|---|---|---|---|---|
| Current ratio | – | – | 7.30 | |
| Interest coverage | – | – | -102.0× | |
| Capex to revenue | – | – | 30.0% | |
| Diluted shares | – | – | 109M |
Cash use needs five years of cash flow figures
Burcon NutraScience does not report operating cash flow and capital expenditure for each of the last five fiscal years.
DuPont needs revenue, assets and equity
This company does not report all three for consecutive years.
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2022 against fiscal 2021
0of 4 tests passed in fiscal 2022. Some tests lack the figures they need.
- ProfitableNet income above zero–
- Cash generatingOperating cash flow above zero-C$5.91M
- Return on assets improvedROA up on the prior year– → –
- Earnings backed by cashOperating cash flow above net income-C$5.91M vs –
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose10.09 → 7.30
- No dilutionShare count did not rise103M → 109M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose0.01 → 0.00